ASCVD Risk Calculator

Estimate 10-year ASCVD risk for primary prevention adults using the ACC/AHA pooled cohort equations, with scope limits, optimal-risk comparison.

Health estimate

Editorial responsibility: Calcipedia editorial team

This page is maintained against the site trust model for its topic and updated when formulas, sources, or guidance materially change.

Reviewed 16 May 2026 Updated 16 May 2026 Contact editorial team

ASCVD risk calculator Educational-only 10-year ASCVD estimation using the ACC/AHA pooled cohort equations for primary prevention adults aged 40 to 79. This tool does not diagnose cardiovascular disease and should not replace clinician judgment.

Pooled cohort context This page calculates the traditional pooled cohort equation estimate. Current ACC/AHA prevention guidance increasingly uses the newer AHA PREVENT equations for primary-prevention decisions, so treat this result as legacy PCE context rather than a complete modern treatment recommendation.

Quick examples

Age Sex Race model Cholesterol unit Total cholesterol Validated range 130-320 mg/dL HDL cholesterol Validated range 20-100 mg/dL Systolic blood pressure Validated range 90-200 mm Hg Blood pressure treatment Diabetes Current smoker Known ASCVD

Model scope

This worksheet is intentionally narrow: adult primary prevention only, age 40 to 79, pooled cohort inputs only, and educational use only. It is designed to support discussion, not to make treatment decisions on its own.

Risk-enhancing factors not in the equation

Select any factors you already know about. They do not change the PCE percentage here, but they flag topics that can refine borderline or intermediate-risk prevention discussions.

Family history of premature ASCVD A close relative with early heart attack, stroke, or related ASCVD can change prevention discussion. LDL-C 160 mg/dL or higher Persistently elevated LDL-C can matter even when the 10-year estimate is not high. Chronic kidney disease Kidney disease is not a direct pooled cohort input but can raise prevention concern. Metabolic syndrome Central weight, triglycerides, glucose, HDL, and blood pressure patterns may cluster risk. Chronic inflammatory condition Examples include rheumatoid arthritis, psoriasis, HIV, or other chronic inflammatory disease. Premature menopause or preeclampsia history Pregnancy and reproductive history can refine risk discussions outside the PCE inputs. South Asian ancestry Some populations may be underestimated by older pooled cohort calibration. Elevated hsCRP, Lp(a), apoB, or triglycerides Additional labs can change how borderline or intermediate estimates are discussed.

Result

5.4%

Estimated 10-year ASCVD risk using white or other male coefficients.

Risk category: Borderline risk
Optimal comparison: 3.6%
Excess risk: 1.8 pts
Relative to optimal: 1.5x

Educational interpretation

Borderline risk: 5% to 7.4% 10-year ASCVD risk.

Educational use only. This estimate supports risk discussion and does not diagnose cardiovascular disease or replace clinician judgment.

No extra risk-enhancing factors selected. The pooled cohort equation does not directly include these factors, so use them as discussion prompts rather than mathematical adjustments.

Input	Value used
Age	55 years
Total cholesterol	213 mg/dL
HDL cholesterol	50 mg/dL
Systolic blood pressure	120 mm Hg
Treatment / diabetes / smoking	Untreated BP, no diabetes, not smoking

Model limitations

ACC/AHA pooled cohort equations were derived for non-Hispanic African American and non-Hispanic White adults. For other populations, this version uses the White/other coefficients and may overestimate or underestimate risk.

Risk bands used here

Low under 5%, borderline 5% to 7.4%, intermediate 7.5% to 19.9%, and high 20% or higher.

About this calculator

Health estimate Reviewed 16 May 2026 Updated 16 May 2026

Editorial responsibility

Calcipedia editorial team

This page is maintained against the site trust model for its topic and updated when formulas, sources, or guidance materially change.

Formula provenance

The methodology summary explains the formula family in use, and the source list points to the primary or authoritative references checked for this topic.

Methodology

Implements the ACC/AHA pooled cohort equations for 10-year ASCVD risk using the ACC/AHA coefficient set for sex-specific African American and White/other models. Inputs are limited to the validated primary-prevention range used by the pooled cohort tool: age 40-79 years, total cholesterol 130-320 mg/dL, HDL cholesterol 20-100 mg/dL, and systolic blood pressure 90-200 mm Hg. Risk bands are displayed as low (<5%), borderline (5% to 7.4%), intermediate (7.5% to 19.9%), and high (>=20%). The page separately notes that newer AHA PREVENT equations are current cardiovascular-kidney-metabolic risk tools and does not treat the older PCE percentage as a complete modern treatment recommendation.

Limitations

For educational use only and not for diagnosis, emergency triage, or stand-alone treatment decisions.
Not appropriate for people with known ASCVD because the pooled cohort equations are intended for primary prevention.
The original model was derived for non-Hispanic African American and non-Hispanic White adults; using the White/other coefficients for other populations may under- or overestimate risk.
Does not directly include coronary artery calcium, family history, chronic kidney disease, lipoprotein(a), apolipoprotein B, inflammatory conditions, or other risk-enhancing factors that may change clinical decisions.

Disclaimer

This calculator is an informational aid only. It does not diagnose cardiovascular disease and does not replace clinician judgment, symptom evaluation, or individualized prevention planning.

Primary health sources

American College of Cardiology — CVD Risk Estimator Plus — Official ACC estimator that documents pooled cohort scope, input ranges, category labels, and the current ACC implementation of the pooled cohort equations.
American Heart Association — PREVENT Risk Calculator — AHA page describing PREVENT equations for cardiovascular-kidney-metabolic risk estimation, including 10-year and 30-year risk context for adults without known cardiovascular disease.
American College of Cardiology — 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease — ACC summary of prevention guidance describing pooled cohort use, risk categories, and the role of risk-enhancing factors and coronary artery calcium.
American College of Cardiology — 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk — ACC summary of the pooled cohort equations, validated age range, model inputs, and intended use in primary prevention.
PubMed — 2013 ACC/AHA guideline on the assessment of cardiovascular risk — PubMed record for the ACC/AHA cardiovascular risk guideline report that introduced the pooled cohort framework.

Change notes

Health change note: the formula, reference ranges, source set, disclaimer, and safety guidance for this calculator were last reviewed on 2026-05-16. Report a correction at contact@calcipedia.org; substantive source or guidance changes refresh both the reviewed date and the updated date shown on the page.

See our calculation methodology and editorial standards, plus the editorial contact route, for how this estimate is produced and corrected.

← All Cardiovascular calculators

Health — Medical

ASCVD risk calculator: estimate 10-year cardiovascular risk with the pooled cohort

An ASCVD risk calculator estimates the chance of a first atherosclerotic cardiovascular disease event over the next 10 years in adults who do not already have known ASCVD.

What this ASCVD risk calculator estimates

The pooled cohort equations estimate the 10-year risk of a first hard ASCVD event. In guideline language, that means nonfatal myocardial infarction, coronary heart disease death, or fatal or nonfatal stroke among adults who are free from ASCVD at the start of the risk period. The model is meant to support a prevention discussion, not to prove that an event will or will not happen in one individual patient.

That distinction matters. A 10-year risk estimate is a population-style probability based on risk-factor patterns in the cohorts used to derive the equations. It is useful for structuring a conversation about prevention, follow-up, and whether more information is needed. It is not a diagnosis of heart disease, a substitute for symptoms review, or a stand-alone reason to start or stop medication without clinical judgment.

Who the model is for and who it is not for

The pooled cohort equations are intended for primary prevention adults aged 40 to 79 years. In other words, this is the part of care where the question is whether someone without known ASCVD may be at enough future risk to justify a deeper prevention discussion. That is why this calculator asks about a known ASCVD history and warns when the case falls outside the intended scope.

It should not be used as a shortcut for people with prior myocardial infarction, stroke, coronary revascularization, or other established ASCVD. Those patients are already in a different clinical pathway because secondary prevention decisions do not depend on the pooled cohort estimate in the same way. The same caution applies to people outside the validated age band, to emergency symptoms, and to cases where the main question is diagnosis rather than prevention.

The inputs that drive the pooled cohort equations

The official pooled cohort model uses a small set of traditional risk factors: age, sex, race model, treated or untreated systolic blood pressure, total cholesterol, HDL cholesterol, current smoking status, and diabetes history. This calculator keeps that input set explicit so users can see the model boundary clearly instead of assuming it includes every cardiovascular risk factor that might matter clinically.

That boundary is one reason the result should be interpreted cautiously. Family history, chronic kidney disease, inflammatory conditions, coronary artery calcium, lipoprotein(a), apolipoprotein B, triglycerides, and pregnancy-related risk history can all matter in real prevention work, yet they are not direct pooled cohort inputs. The estimate is still useful, but only when understood as one part of a broader clinical picture.

How the risk bands are interpreted

Current ACC prevention discussions commonly group 10-year ASCVD estimates into four bands: low risk under 5%, borderline risk from 5% to 7.4%, intermediate risk from 7.5% to 19.9%, and high risk at 20% or higher. Those categories make the estimate easier to use in shared decision-making because they provide a common starting point for deciding whether more discussion, more testing, or preventive therapy might be appropriate.

The category is still not the whole answer. The ACC guidance emphasizes a clinician-patient discussion rather than a purely automated decision. Borderline and intermediate estimates may need risk-enhancing factors or coronary artery calcium scoring to refine the picture. Even a low estimate does not erase symptoms, and a high estimate does not eliminate the need for individualized judgment.

Pooled cohort equations versus PREVENT

The pooled cohort equations remain a common search intent because many articles, EHR prompts, and older clinical workflows still refer to a 10-year ASCVD risk calculator. They are also useful for understanding the historical ACC/AHA risk bands behind many cholesterol and primary-prevention discussions.

However, newer AHA PREVENT equations were designed from contemporary data and include cardiovascular, kidney, and metabolic health context. PREVENT can estimate 10-year and 30-year risk for broader cardiovascular outcomes in adults starting at age 30, while this page deliberately keeps the older PCE calculation separate and labelled. That separation prevents a pooled cohort percentage from being mistaken for the full current ACC/AHA risk-estimation workflow.

Use this page when you specifically need the traditional pooled cohort equation or want to understand a legacy ASCVD percentage.
Use a PREVENT-based tool when the clinical question is current cardiovascular-kidney-metabolic risk estimation, 30-year risk, heart failure risk, or risk assessment in adults aged 30 to 39.
Do not compare PCE and PREVENT percentages as if they are interchangeable; they use different models, populations, inputs, and outcomes.

How risk-enhancing factors change the conversation

Competitor tools often stop at the percentage or immediately attach medication language to it. A safer ASCVD calculator should make the missing context visible. Family history of premature ASCVD, chronic kidney disease, chronic inflammatory disease, metabolic syndrome, South Asian ancestry, premature menopause or preeclampsia, elevated triglycerides, Lp(a), apoB, or hsCRP can all matter without being direct pooled cohort inputs.

That is why the calculator now includes a risk-enhancing-factor checklist. Selecting a factor does not mathematically adjust the PCE result, because the pooled cohort equation does not include those variables. Instead, the checklist turns the result into a better discussion aid: if the estimate is borderline or intermediate, selected factors can help explain why a clinician might review coronary artery calcium, lipid details, kidney markers, or family history more closely.

Why this calculator asks for a race model

The original pooled cohort equations were derived for non-Hispanic African American adults and non-Hispanic White adults using sex-specific models. For people outside those groups, ACC guidance notes that the White equations may be used as an approximation, but the estimate may under- or overestimate risk depending on the population. That is why this page labels the choice as a race model rather than implying that the estimate is equally calibrated for every group.

This limitation is important enough to state plainly on the page. The estimate may underestimate risk in some groups, such as some South Asian populations and some Puerto Rican populations, and may overestimate risk in others, such as some East Asian or Mexican American populations. The output is therefore best understood as a discussion aid, especially when the individual does not match the derivation cohorts closely.

Worked example: a borderline primary-prevention profile

A commonly cited example from ACC guidance is a 55-year-old White man with total cholesterol 213 mg/dL, HDL cholesterol 50 mg/dL, untreated systolic blood pressure 120 mm Hg, no smoking, and no diabetes. In this worksheet, that profile lands at about a 5.4% 10-year ASCVD risk, which places it in the borderline range rather than the low or intermediate range.

That example shows the main value of an ASCVD risk calculator. The answer is not simply 'high' or 'normal.' It is a structured probability estimate that helps frame the next question: is this a straightforward lifestyle conversation, a case for looking at risk-enhancing factors, or a situation where additional testing might refine the estimate? The pooled cohort equations are most helpful when they trigger that next layer of discussion.

Why this page is educational only

Medical calculators can become misleading when they present a clean number without enough context. This page is deliberately narrower. It estimates 10-year ASCVD risk for primary prevention adults in the validated age band and labels cases outside that scope. It does not diagnose coronary disease, stroke risk from active symptoms, hypertensive urgency, familial lipid disorders, or treatment suitability in isolation.

That educational-only framing is not a hedge; it is part of safe use. Prevention decisions often turn on factors beyond the pooled cohort inputs, including current symptoms, prior disease, medication history, pregnancy history, family history, lab detail, and patient preferences. The estimate is useful precisely because it is one clear part of that larger conversation rather than a replacement for it.

Frequently asked questions

What does ASCVD stand for?

ASCVD stands for atherosclerotic cardiovascular disease. In the pooled cohort equations, the 10-year estimate refers to the risk of a first hard ASCVD event such as nonfatal myocardial infarction, coronary heart disease death, or fatal or nonfatal stroke.

Can this calculator diagnose heart disease?

No. This calculator estimates 10-year ASCVD risk for prevention discussions. It does not diagnose coronary artery disease, stroke, or any other condition. Symptoms, examination findings, imaging, and clinician assessment still matter.

Who should use an ASCVD risk calculator?

The pooled cohort equations are intended for primary prevention adults aged 40 to 79 years who do not already have known ASCVD. That is the group in which the model was designed to support shared decision-making about risk reduction.

Should I use this if I already had a heart attack or stroke?

No. People with known ASCVD are outside the intended scope of the pooled cohort equations. Once ASCVD is already present, the clinical question is secondary prevention, which follows a different decision pathway than a primary-prevention risk estimate.

Why does the calculator ask for race?

The original pooled cohort equations were derived using sex-specific models for non-Hispanic African American adults and non-Hispanic White adults. For other populations, ACC materials note that the White equations may be used as an approximation, but the estimate may under- or overestimate risk depending on the group.

What is considered low, borderline, intermediate, or high risk?

On this page, the same risk bands used in ACC prevention discussions are shown: low under 5%, borderline 5% to 7.4%, intermediate 7.5% to 19.9%, and high 20% or higher. These labels help organize discussion, but they are not the same as a diagnosis.

Does a high result mean I need a statin?

Not by itself. A high estimate is a reason for a clinician-patient discussion, not a fully automated prescription decision. ACC guidance emphasizes considering the overall clinical context, risk-enhancing factors, and in selected cases coronary artery calcium scoring.

Why does the calculator compare my risk with an optimal risk?

The optimal comparison gives a reference point using the same age, sex, and race model but with favorable benchmark values such as total cholesterol 170 mg/dL, HDL 50 mg/dL, untreated systolic blood pressure 110 mm Hg, no smoking, and no diabetes. It is not a target you must personally achieve; it is a contextual benchmark.

Can younger adults use this calculator?

Not for the 10-year pooled cohort estimate. The validated age band is 40 to 79 years. ACC guidance discusses lifetime or 30-year risk approaches in younger adults, but those are different tools and should not be confused with this 10-year estimator.

What important factors are not included in the pooled cohort equations?

The model does not directly include family history, coronary artery calcium, chronic kidney disease, inflammatory disease, lipoprotein(a), apolipoprotein B, triglycerides, or many other factors that can influence prevention decisions. That is why borderline and intermediate estimates often need a wider clinician review instead of a calculator-only conclusion.

Is PREVENT replacing the older ASCVD risk calculator?

PREVENT is the newer AHA cardiovascular-kidney-metabolic risk framework and is increasingly used in current ACC/AHA prevention tools. This page still calculates the older pooled cohort equation because many users specifically search for that ASCVD percentage, but the result should be interpreted as PCE context rather than a complete current prevention workflow.

Do risk-enhancing factors change the number shown here?

No. The checklist does not change the pooled cohort equation percentage because those factors are not direct PCE inputs. It shows issues that may change a clinician-patient discussion, especially when the estimate is borderline or intermediate.

Also in Cardiovascular

Cardiac Output Calculator Cholesterol Ratio Calculator LDL Cholesterol Calculator